Category Archives: News and Events

BriaCell Provides Clinical Update on its Lead Immunotherapy Drug in Advanced Breast Cancer

BERKELEY, Calif. and VANCOUVER, British Columbia, January 3, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell To Attend Biotech Showcase™ 2018

BERKELEY, Calif. and VANCOUVER, British Columbia, January 2, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Announces Closing of Warrant Incentive Program

Berkeley, CA and Vancouver, BC – December 21, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

Dr. Bill Williams Guest Appearance at “CEO Money” Radio Show

BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 05, 2017 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

Bill Williams M.D. from BriaCell on CEO Money

Click here to read more ...

BriaCell Announces Advancement of its Small Molecule Program and Patent Allowance

BERKELEY, Calif. and VANCOUVER, British Columbia, November 13, 2017 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Provides Clinical Update

BERKELEY, Calif. and VANCOUVER, British Columbia, November 6, 2017 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

Expanding Breast Cancer Treatment Options: A Q&A with BriaCell on their Cancer Immunotherapy and their Pipeline

Expanding Breast Cancer Treatment Options: A Q&A with BriaCell on their Cancer Vaccine and their ...

FDA Approves the Roll-Over Combination Study with Checkpoint Inhibitor Immunotherapies to Allow Continued Access to their Immunotherapy in Patients with Advanced Breast Cancer

BERKELEY, Calif. and VANCOUVER, British Columbia, Oct 30, 2017 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Announces Warrant Incentive Program

Berkeley, CA and Vancouver, BC – October 13, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...